Forbearance Agreements in the Pharmaceuticals Industry
29 Contracts & Agreements
- ADIAL PHARMACEUTICALS, INC. (1 contract)
- Aegerion Pharmaceuticals, Inc. (4)
- Baudax Bio, Inc. (1)
- BIODELIVERY SCIENCES INTERNATIONAL INC (1)
- Canbiola, Inc. (1)
- Cannabics Pharmaceuticals Inc. (2)
- Cerecor Inc. (2)
- Cure Pharmaceutical Holding Corp. (1)
- Egalet Corp (4)
- Evofem Biosciences, Inc. (2)
- Exactus, Inc. (1)
- INNOVATE BIOPHARMACEUTICALS, INC. (3)
- Kedem Pharmaceuticals Inc. (2)
- Notis Global, Inc. (1)
- SYNERGY PHARMACEUTICALS, INC. (2)
- TILT Holdings Inc. (1)
- Third Forbearance Agreement, dated as of September (Cerecor Inc., Filed With SEC on September 13, 2023)
- Forbearance Agreement, dated as of July (Cerecor Inc., Filed With SEC on July 21, 2023)
- Amendment No. 2 to the Forbearance Agreement (INNOVATE BIOPHARMACEUTICALS, INC., Filed With SEC on July 18, 2023)
- Forbearance Agreement, dated as of June 29, 2023, by and among Baudax Bio, Inc, Baudax Bio N.A. LLC, Baudax Bio Limited, Wilmington Trust, National Association, and the Lender... (Baudax Bio, Inc., Filed With SEC on July 5, 2023)
- Consent, Confirmation, Limited Waiver and Forbearance Agreement dated May 15, 2023, by and among TILT Holdings Inc., Jimmy Jang, L.P., Baker Technologies, Inc., Commonwealth... (TILT Holdings Inc., Filed With SEC on May 19, 2023)
- Amendment No. 1 to the Forbearance Agreement, dated May 18, 2023 (INNOVATE BIOPHARMACEUTICALS, INC., Filed With SEC on May 19, 2023)
- Forbearance Agreement, dated April 26, 2023 (INNOVATE BIOPHARMACEUTICALS, INC., Filed With SEC on April 27, 2023)
- Arena Forbearance Agreement (Canbiola, Inc., Filed With SEC on April 17, 2023)
- Forbearance Agreement, dated as of September (Evofem Biosciences, Inc., Filed With SEC on September 16, 2022)
- Forbearance Agreement, dated as of September (Evofem Biosciences, Inc., Filed With SEC on September 16, 2022)
- Form of Forbearance Agreement (Cannabics Pharmaceuticals Inc., Filed With SEC on March 16, 2022)
- Form of Forbearance Agreement (Cannabics Pharmaceuticals Inc., Filed With SEC on February 17, 2022)
- Forbearance Agreement (Cure Pharmaceutical Holding Corp., Filed With SEC on January 7, 2022)
- FORBEARANCE AGREEMENT (Exactus, Inc., Filed With SEC on May 22, 2020)
- The Forbearance Agreement entered into with YA II PN, LTD, Hudson Street, LLC, and the Company on October 31, 2018 (Notis Global, Inc., Filed With SEC on January 8, 2019)
- Amendment to Limited Forbearance Agreement, dated as of December 5, 2018, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative... (SYNERGY PHARMACEUTICALS, INC., Filed With SEC on December 6, 2018)
- Limited Forbearance Agreement, dated as of November 21, 2018, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and... (SYNERGY PHARMACEUTICALS, INC., Filed With SEC on November 26, 2018)
- Amendment No. 3 to Forbearance Agreement, dated October 24, 2018, by and among the Company, the Guarantors and the Supporting Holders (Egalet Corp, Filed With SEC on October 25, 2018)
- Amendment No. 2 to Forbearance Agreement, dated October 21, 2018, by and among the Company, the Guarantors and the Supporting Holders (Egalet Corp, Filed With SEC on October 22, 2018)
- Amendment to Forbearance Agreement, dated October 14, 2018, by and among the Company, the Guarantors and the Supporting Holders (Egalet Corp, Filed With SEC on October 15, 2018)
- Forbearance Agreement, dated September 18, 2018, by and among the Company, the Guarantors and the Supporting Holders (Egalet Corp, Filed With SEC on September 19, 2018)
- Salary Forbearance Agreement with William B. Stilley, III dated August 17, 2016 (ADIAL PHARMACEUTICALS, INC., Filed With SEC on September 7, 2017)
- SIXTH AMENDMENT TO FORBEARANCE AGREEMENT (Aegerion Pharmaceuticals, Inc., Filed With SEC on November 4, 2016)
- FIRST AMENDMENT TO FORBEARANCE AGREEMENT (Aegerion Pharmaceuticals, Inc., Filed With SEC on March 15, 2016)
- SECOND AMENDMENT TO FORBEARANCE AGREEMENT (Aegerion Pharmaceuticals, Inc., Filed With SEC on March 15, 2016)
- THIRD AMENDMENT TO FORBEARANCE AGREEMENT (Aegerion Pharmaceuticals, Inc., Filed With SEC on March 15, 2016)
- Forbearance Agreement with the Investor dated October 27, 2011 (Kedem Pharmaceuticals Inc., Filed With SEC on November 4, 2011)
- Forbearance Agreement with the Investor dated October 27, 2011 (Kedem Pharmaceuticals Inc., Filed With SEC on November 4, 2011)
- LIMITED WAIVER AND FORBEARANCE AGREEMENT (BIODELIVERY SCIENCES INTERNATIONAL INC, Filed With SEC on August 26, 2004)
